Project measures / variables set:   Xenakis1   latency_Rx


  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Xenakis1 - latency to move all four paws (extrapyramidal symptoms), treatment group





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 1 43145.911 43145.911 236.2283 < 0.0001
sex 1 124.5597 124.5597 0.682 0.4096
strain 36 29770.3298 826.9536 4.5277 < 0.0001
group:sex 1 102.2504 102.2504 0.5598 0.455
group:strain 36 21703.1942 602.8665 3.3008 < 0.0001
sex:strain 36 7347.2053 204.089 1.1174 0.3042
group:sex:strain 36 9677.3466 268.8152 1.4718 0.0465
Residuals 275 50227.36 182.6449

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Xenakis1 111156 inclined screen test haloperidol latency to move all four paws (extrapyramidal symptoms), treatment group   [s]   pre-treatment  latency_Rx_pre CC RIX 72 both 7-9wks
Xenakis1 111157 inclined screen test haloperidol latency to move all four paws (extrapyramidal symptoms), treatment group   [s]   post-treatment  latency_Rx_post CC RIX 70 both 7-9wks